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Abstract
Background: This study aimed to assess the trends in the prevalence and levels of risk factors and mortality from
main non-communicable diseases in the Lithuanian population aged 45–64 years during 1985 to 2013.
Methods: Data from four general population surveys conducted between 1985 and 2008 were used. All these
surveys were carried out in Kaunas city and five randomly selected municipalities of Lithuania. Risk factors measured
at each survey included regular smoking, overweight, obesity, arterial hypertension, and high levels of blood lipids.
In total, data of 10,719 subjects (4,965 men and 5,754 women) aged 45–64 were analysed. Trends in standardized
all-cause mortality and mortality from cardiovascular disease (CVD), coronary heart disease (CHD), and malignant
neoplasms were estimated for both sexes by joinpoint regression analysis.
Results: In 1985–2013, some favourable trends were observed in the age-standardized mean levels and prevalence
of risk factors and mortality from main non-communicable diseases in the Lithuanian middle-aged population.
The mean values of blood lipids (with the exception of triglycerides) and the prevalence of dyslipidemias declined.
In women, mean levels of systolic blood pressure and body mass index decreased, while in men, the levels of these
factors increased. The prevalence of arterial hypertension and obesity increased in men. The proportion of obese
women decreased. Smoking prevalence increased in both men and women. From 2007 to 2008, significant
downward trends, which were steeper in women than in men, were observed in all-cause, CVD, and CHD mortality.
Conclusions: Despite the favourable changes in some risk factors and mortality rates, the prevalence of risk factors
and mortality from main non-communicable diseases in Lithuania are still high. This indicates the importance of the
ongoing primary and secondary prevention and optimal treatment of these diseases.
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Background
Cardiovascular disease (CVD) and cancer are major
public health problems in Lithuania, as in many other
parts of Europe and the world [1–3]. CVD mortality rates
have almost halved in most western European countries
over the last forty years [4–6]. From 2000 to 2010, global
cancer mortality decreased annually by 1.2 % for males
and 0.8 % for females in 60 countries [7].
In Lithuania, CVD and cancer mortality rates among
men are higher than in Western European countries
[8, 9]. In 2012, mortality rates from CVD were 616.0
per 100,000 men in Lithuania, compared to 253.9 per
100,000 men in 27 countries of the European Union
(EU). Mortality rates from malignant neoplasms were
276.6 and 216.0 per 100,000 men, respectively [6].
Similarly to men, more than two-fold higher CVD
mortality rates were observed among Lithuanian
women, as compared to EU women (340.1 and 165.9
per 100,000 women, respectively), whereas female
mortality from malignant neoplasms showed no sig-
nificant difference between the two compared regions
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(128.2 per 100,000 women in Lithuania and 127.6 per
100,000 women in EU) [6].
Previous epidemiologic studies have shown that the
largest proportion of the reduction in mortality from
CVD and other chronic non-communicable diseases can
be attributed to improvements in lifestyle and other risk
factors, and evidence-based pharmacological and inter-
ventional therapies [10–12]. Differences in the extent
and timing of the decline in the risk factor prevalence
and mortality rates indicate the need for analysing time
trends in the prevalence of risk factors and the mortality
from chronic non-communicable diseases over different
time periods and across geographic regions.
In Lithuania, temporal trends in the prevalence of risk
factors and mortality from chronic non-communicable
diseases have been explored in several epidemiological
studies [13–15]. However, these studies were typically
based on limited population groups or regions (either
urban or rural), and therefore, did not present the
national-level data. The nationally representative Lithu-
anian Health Behaviour Monitoring focused only on the
trends in lifestyle risk factors and self-reported weight
status [16]. Mortality rates were not linked to the trends
in risk factors [3, 17, 18].
The aim of this study was to estimate the trends in the
prevalence and levels of risk factors and mortality from
main non-communicable diseases in the Lithuanian
population aged 45–64 years during 1985–2013.
Methods
Study sample
Cross-sectional surveys of the samples representing the
Lithuanian population aged 45–64 years were performed
in 1986–1987, 1992–1993, 2001–2002, and 2006–2008.
All these surveys were carried out in Kaunas, the second
largest Lithuanian city (with a population of approxi-
mately 300,000 people), and in five municipalities of
Lithuania (Joniskis, Kaisiadorys, Kupiskis, Kretinga,
and Varena), with populations ranging from 20,000 to
45,000. These municipalities were randomly selected
from the northern, southern, eastern, western, and
central parts of Lithuania. For each survey, an inde-
pendent random sample, stratified by gender and age
(four age groups: 45–49, 50–54, 55–59, and 60–64
years), was drawn from the Kaunas population regis-
ter and from the lists of the inhabitants registered at
the primary health care centres of five municipalities.
In total, data of 10,719 subjects (4,965 men and 5,754
women) aged 45–64 were analysed. The response rate
in the surveys varied between 58.1 and 69.6 %.
All four studies were approved by the Lithuanian
Bioethics Committee. All respondents provided written
informed consent. Data of individual participants were
not reported.
Health examination of random samples
In each survey, blood pressure (BP), weight, height, and
blood lipids were measured using the same methodology.
The same questionnaires were used in order to obtain
required information.
Measurements
BP was measured twice, using a mercury sphygmoman-
ometer and appropriately sized arm cuffs on the right
arm. The initial measurement was performed after five
minutes of rest on the right arm. After two minutes, the
second measurement was made. The Korotkoff phase 1
(beginning of the sound) and the fifth phase of Korotkoff
(disappearance of the sound) were recorded as systolic
and diastolic BP. The mean of two readings was used.
Hypertension was defined as mean systolic BP of at least
140 mmHg and/or mean diastolic BP of at least 90 mmHg,
or BP <140/90 mmHg using antihypertensive medication
for the last two weeks before examination. Weight and
height were measured with a calibrated medical scale, and
without shoes or heavy clothes. Body mass index (BMI)
was calculated as the weight in kilograms divided by
the height in meters squared (kg/m2). Normal weight
was defined as BMI <25.0 kg/m2, overweight as BMI
25.0–29.99 kg/m2, and obesity as BMI ≥30.0 kg/m2.
A venous blood specimen was taken to determine lipid
levels. Participants were asked to abstain from food in-
take at least 12 h before the examination. Lipid levels in
blood serum were measured by conventional enzymatic
method. All laboratory analyses were made in the
certified laboratories which used stringent quality
control measures. Dyslipidemias were defined using the
following criteria: high total cholesterol level - ≥5 mmol/L;
high low-density lipoprotein (LDL) cholesterol level -
≥3 mmol/L; low high-density lipoprotein (HDL) choles-
terol level - for men <1.0 mmol/L and for women
<1.2 mmol/L; elevated triglyceride level - ≥1.7 mmol/L.
The structured questionnaire included questions
regarding the respondent’s age, smoking status, anti-
hypertensive treatment, lipid-lowering treatment, and
other factors. The question about the use of lipid-
lowering medication was asked in all surveys, except the
first one. According to smoking status, participants were
classified as never smokers, former smokers, and current
smokers (smoking at least one cigarette per day).
We calculated the Systematic Coronary Risk Evaluation
(SCORE) values using the high-risk version of SCORE,
recommended by the European Society of Cardiology
[19]. Respondents were categorized into four groups
according to SCORE values: 0, 1–4, 5–9, and ≥10 %.
Mortality data
The Lithuanian Department of Statistics and the Health
Information Centre of the Institute of Hygiene were the
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primary sources of mortality and population data. All
deaths for population aged 45–64 years were recorded
from 1985 to 2013. Death cases were classified into fol-
lowing groups based on the underlying cause of death
and coded by versions 9 and 10 of the International
Classification of Diseases (ICD): 1. CVD mortality in-
cluded codes 390–458 of ICD-9 and I00-I99 codes of
ICD-10; 2. Deaths from CHD included codes 410–414
of ICD-9 and I20-I25 of ICD-10; 3. Deaths from malig-
nant neoplasms included codes 140–208 of ICD-9 and
C00-C97 of ICD-10; 4. All-cause mortality was defined
as 001-E999 codes of ICD-9 and A00-Z99 codes of
ICD-10. Mid-year population estimates for the age group
45–64 have been used in rate calculations.
Statistical analysis
All statistical analyses were performed using the statistical
software package IBM SPSS Statistics 20. The data were
weighted to match the age distribution of the Lithuanian
population aged 45–64 years in 2008. The continuous var-
iables are presented as means and standard deviations
(SD), and categorical variables are expressed as propor-
tions. The differences in age-adjusted means of variables
between the surveys were assessed using analysis of vari-
ance and Bonferroni multiple comparison tests. A χ2 test
was used for assessing the differences in proportions.
All mortality rates presented were directly standardized
by the European standard population. The 95 % confi-
dence intervals (CI) were calculated assuming the Poisson
distribution within the age strata. The standardized mor-
tality rate trends by sex were estimated by joinpoint re-
gression analysis [20]. For all mortality rates of interest
(all-cause, CVD mortality, CHD mortality, and mortality
from malignant neoplasms), four joinpoint regression
models were created. The true number of joinpoints (from
0 to 3) was determined in the permutation test. Standard-
ized rates were used as the dependent variable, whereas
the year of death was entered in the model as the inde-
pendent variable. The estimated regression coefficient
(beta) multiplied by 100 was reported as the estimated
annual percentage change (APC). The 95 % CI of the APC
was obtained in the usual manner, from the standard error
of the regression coefficient. Differences in rates at the
level of p < 0.05, using a two-tailed test, were reported as
statistically significant.
Results
Age-standardized mean levels of risk factors, SCORE
values, and the prevalence of main risk factors among
Lithuanians aged 45–64 years are presented in Table 1
(men) and Table 2 (women). Age-adjusted mean systolic
BP significantly increased from 141.8 mmHg in 1986–
1987 to 145.5 mmHg in 2006–2008 in men and signifi-
cantly decreased from 142.3 mmHg to 139.8 mmHg in
women during the same period. In men, the prevalence
of arterial hypertension showed a significant increase
from 62.7 % in the first survey to 74.0 % in the last sur-
vey, while no significant trend was found in women.
A significant increase in mean BMI in men and a signifi-
cant decrease in mean BMI in women was observed from
1986–1987 to 2006–2008. The proportion of overweight
persons significantly decreased in men and remained rela-
tively stable in women, whereas the prevalence of obesity
significantly increased in men and decreased in women
over the same period.
Between the first and the last survey, the mean levels
of total cholesterol and LDL cholesterol significantly de-
creased in both men and women. The decrease in the
mean level of LDL cholesterol was 16.2 % in men and
20.5 % in women. During the 20-year period, an increase
of mean HDL cholesterol level by 0.08 mmol/L in men
and by 0.09 mmol/L in women was observed. Age-
adjusted mean levels of triglycerides significantly in-
creased in both men and women. The prevalence of high
levels of total cholesterol and LDL cholesterol and low
level of HDL cholesterol significantly decreased in men
and women between the first and the last surveys. Con-
versely, the proportion of men and women with high
levels of triglycerides significantly increased.
Between 1986–1987 and 2006–2008, an increase in
the prevalence of regular smoking by 1.2 times in men
(from 36.5 to 44.6 %) and by 6 times in women (from
2.6 to 15.7 %) was observed.
In men, the mean SCORE value was significantly
higher in 2006–2008, as compared to the survey in
1999–2002. Similarly, in women, the highest mean
SCORE value was found in the last survey.
Age-standardized mortality rates in 45–64 year-old
Lithuanian men and women and mortality trends be-
tween 1985 and 2013 are presented in Tables 3 and 4. In
women, all four analysed mortality rates were significantly
lower in 2013, as compared to 1985. A similar pattern in
differences between mortality rates at the beginning and
at the end of the study period was observed in men, with
the exception of all-cause mortality rate which did not
differ significantly between 1985 and 2013. For the whole
study period, only a tendency towards decreasing mortal-
ity rates (with the exception of all-cause mortality) was
observed in men aged 45–64 years, while the decrease in
mortality rates from CVD and malignant neoplasms was
statistically significant in women .
In men, three points of changes in the all-cause mortal-
ity trend were detected during the whole study period
(Table 5). The periods 1985–1995 and 2000–2007 showed
a significant increase in male all-cause mortality, while
decreasing mortality rates were found in the period
2008–2013. The similar pattern of all-cause mortality
trends for the period 1985–2013 was observed in women.
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The steepest significant annual increase of all-cause
mortality was observed in 1985–1995 (APC = +4.4 % for
men and APC = +2.3 % for women), while the steepest
significant annual decline of mortality was observed in
2008–2013 for men (APC = −4.9 %) and in 1996-2000
for women (APC = −4.7 %).
In men, CVD mortality rates significantly increased
in 1985–1994 and 1999–2007, while among women, a
significant increase in mortality rates was observed only in
1985–1995. The steepest annual decline in mortality from
CVD was found among men in 2008–2013 (APC =
−5.0 %) and among women in 1996–2000 (APC = −7.6 %).
CHD mortality rates changed the trend direction from
increasing to decreasing twice during the study period in
both sexes. In men, the highest annual increase in CHD
mortality was observed in 1985–1994 (APC = +4.3 %),
while in women, a similar increase in mortality was found
in 2000–2006 (APC = +4.4 %). The steepest annual decline
in CHD mortality was observed in men during the period
1995–1998 (APC = −11.1 %, p = 0.005), and in women,
during the period 1996–1999 (APC = −5.2 %, p = 0.002).
In men, mortality from malignant neoplasms changed
the trend direction twice during the study period, in 1993
and 2007, while in women, only once, in 1994. The
steepest annual increase in mortality from malignant
neoplasms was observed among men in 1985–1993
(APC = +2.1 %, p < 0.001), while the steepest decline
of this mortality rate was registered in 2008–2013
(APC = −2.9 %, p < 0.001). In women, mortality from ma-
lignant neoplasms showed a continuously decreasing
trend starting from 1994 (APC = −0.9 %, p < 0.001).
Discussion
This is the first large nationwide study to address the
trends in the prevalence of the main risk factors of
chronic non-communicable diseases and mortality rates
in Lithuania over a period of more than 20 years. We
determined gender-specific trends in the mean levels
Table 1 Age-standardized means of risk factors, SCORE values, and prevalence of risk factors in men
Mean values and prevalence 1986–1987 1992–1993 1999–2002 2006–2008 P ANOVA
n = 1391 n = 953 n = 1096 n = 1525
Mean systolic BP, mmHg 141.8 (20.4) 142.5 (22.2) 140.6 (21.7) 145.5*, **, *** (22.2) <0.001
Mean BMI, kg/m2 27.6 (3.92) 27.1 (4.10) 27.7** (4.64) 28.1*, ** (5.13) <0.001
Mean total cholesterol, mmol/L 6.12 (1.12) 6.03 (1.23) 5.93* (1.32) 5.62*, **, *** (1.11) <0.001
Mean LDL cholesterol, mmol/L 4.19 (1.13) 4.04* (1.10) 3.77*, ** (1.30) 3.51*, **, *** (1.03) <0.001
Mean HDL cholesterol, mmol/L 1.29 (0.45) 1.32 (0.44) 1.41*, ** (0.42) 1.37* (0.42) <0.001
Mean triglycerides, mmol/L 1.43 (0.82) 1.46 (1.04) 1.66*, ** (1.01) 1.81*, **, *** (1.12) <0.001
Mean SCOREa value, % 4.75 (4.86) 4.75 (4.94) 4.61 (4.89) 5.25*** (5.36) 0.005
P from chi squared
Arterial hypertension, % 62.7 63.2 61.7 74.0*, **, *** <0.001
Regular smoking, % 36.5 34.2 39.4 44.6*, **, *** <0.001
Total cholesterol ≥5.0 mmol/L, % 85.7 78.9* 76.1* 70.2*, **, *** <0.001
LDL cholesterol ≥3.0 mmol/L, % 86.1 83.9 70.4*, ** 68.2*, ** <0.001
HDL cholesterol <1.0 mmol/L, % 27.9 23.6 14.9*, ** 15.0*, ** <0.001
Triglycerides ≥1.7 mmol/L, % 24.8 25.5 36.3*, ** 44.6*, **, *** <0.001
Normal weight, BMI <25.0 kg/m2, % 25.8 32.6* 28.4 29.0
Overweight, BMI 25.0–29.9 kg/m2, % 49.0 46.8 44.9 40.6*, ** <0.001
Obesity, BMI ≥30.0 kg/m2, % 25.2 20.6 26.7** 30.5*, **
SCOREa (%):
0 % 7.4 6.7 8.0 8.8 0.001
1–4 % 54.2 53.9 56.0 47.2*, **, ***
5–9 % 25.3 27.3 23.4 28.7***
≥10 % 13.1 12.2 12.6 15.3
Abbreviations: CVD cardiovascular disease, BMI body mass index, BP blood pressure, SD standard deviation, HDL high-density lipoproteins, LDL low-density lipoproteins,
SCORE Systematic Coronary Risk Evaluation
*p < 0.05 compared to 1986–1987, Bonferroni test
**p < 0.05 compared to 1992–1993, Bonferroni test
***p < 0.05 compared to 1999–2002, Bonferroni test
awithout CVD, other risk factors presented for all participants
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and the prevalence of risk factors in the Lithuanian
population aged 45 to 64 years from 1986 to 2008. Both
all-cause and cause-specific mortality for Lithuanian
men and women were analysed from 1985 to 2013.
In the male population, we observed a significant in-
crease in the prevalence of arterial hypertension and in
the mean values of systolic BP. The increasing trends in
the mean level of systolic BP contradict the global trends
during a similar period. The analysis of data from 199
countries showed that the mean systolic BP decreased
by 0.8 mmHg per decade in men and by 1.0 mmHg in
women between 1980 and 2008. In Western Europe,
systolic BP decreased by 2.0 mmHg per decade in men
and by 3.5 mmHg or more in women [21]. The increas-
ing prevalence of obesity and sedentary lifestyle are
usually indicated as factors contributing to the adverse
Table 3 Age-standardized mortality ratesa and trends in 45–64 year-old Lithuanian men, 1985–2013
Causes of death Years Time period
1985 2013 1985 - 2013
Rate 95 % CI Rate 95 % CI APC 95 % CI p-value
All causes of death 1714.7 1671.2–1758.2 1669.6 1628.5–1710.8 +0.30 −1.2–+1.8 0.700
CVD 672.8 645.3–700.4 587.1 562.6–611.7 −0.10 −1.5–+1.4 0.900
CHD 471.2 448.2–494.3 352.4 333.4–371.5 −0.60 −1.9–+1.2 0.400
Malignant neoplasms 426.0 404.1–447.9 377.5 357.8–397.8 −0.50 −1.0–+0.0 0.100
Abbreviations: APC annual percent change, CHD coronary heart disease, CI confidence interval, CVD cardiovascular disease
aper 100,000 population
Table 2 Age-standardized means of risk factors, SCORE values, and prevalence of risk factors in women
Mean levels and prevalence of
factors
1986–1987 1992–1993 1999–2002 2006–2008 P ANOVA
n = 1437 n = 1055 n = 1343 n = 1919
Mean systolic BP, mmHg 142.3 (22.7) 142.5 (25.2) 137.7*, *** (22.6) 139.8*, **, *** (23.0) <0.001
Mean BMI, kg/m2 30.4 (5.24) 29.0*(5.25) 29.3*(5.82) 28.7*, *** (5.91) <0.001
Mean total cholesterol, mmol/L 6.42 (1.21) 6.21*(1.33) 6.04*, *** (1.38) 5.68*, **, *** (1.16) <0.001
Mean LDL cholesterol, mmol/L 4.35 (1.10) 4.26 (1.24) 3.82*, *** (1.34) 3.46*, **, *** (1.06) <0.001
Mean HDL cholesterol, mmol/L 1.45 (0.46) 1.44 (0.43) 1.55*, *** (0.39) 1.54*, ** (0.39) <0.001
Mean triglycerides, mmol/L 1.34 (0.64) 1.27 (0.70) 1.51*, *** (0.84) 1.59*, **, *** (0.83) <0.001
Mean SCOREa value, % 1.45 (1.88) 1.34 (1.73) 1.35 (1.79) 1.66*, **, *** (1.91) <0.001
P from chi squared
Arterial hypertension, % 59.1 59.5 50.0*, *** 58.9*** <0.001
Regular smoking, % 2.6 3.2 9.0*, *** 15.7*, **, *** <0.001
Total cholesterol ≥5.0 mmol/L, % 89.8 83.5* 77.0*, *** 72.2*, **, *** <0.001
LDL cholesterol ≥3.0 mmol/L, % 89.4 86.9 71.5*, *** 65.4*, **, *** <0.001
HDL cholesterol <1.2 mmol/L, % 30.5 30.7 17.1*, *** 18.2*, *** <0.001
Triglycerides ≥1.7 mmol/L, % 21.0 19.8 29.0*, *** 37.2*, **, *** <0.001
Normal weight, BMI <25.0 kg/ m2, % 14.4 24.3* 24.2* 29.1*, **, ***
Overweight, BMI 25.0–29.9 kg/m2, % 35.2 38.5 34.7 35.1 <0.001
Obesity, BMI ≥30.0 kg/m2, % 50.4 37.2* 41.1* 35.8*, ***
SCOREa (%):
0 % 32.0 33.4 34.9 28.6*** 0.008
1–4 % 60.6 59.7 58.8 62.7
5–9 % 6.4 6.3 5.7 8.1
≥10 % 0.9 0.7 0.6 0.6
Abbreviations: CVD, cardiovascular disease, BMI body mass index, BP blood pressure, SD standard deviation, HDL high-density lipoproteins, LDL low-density lipoproteins,
SCORE Systematic Coronary Risk Evaluation
*p < 0.05 compared to 1986–1987, Bonferroni test
**p < 0.05 compared to 1992–1993, Bonferroni test
***p < 0.05 compared to 1999–2002, Bonferroni test
awithout CVD, other risk factors presented for all participants
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trend in arterial hypertension [22, 23]. Our data con-
firmed the increase in the mean BMI of Lithuanian men.
During the period 1983–2008, the prevalence of physical
inactivity did not show a statistically significant trend for
the Lithuanian urban population aged 45–64 years; how-
ever, the proportion of population with low levels of
physical activity was high [13]. Other important risk fac-
tors for arterial hypertension are alcohol consumption
and high sodium intake [24, 25]. The data of the Lithu-
anian Health Behaviour Monitoring among the popula-
tion aged 20–64 showed that alcohol consumption had
increased over the last two decades, especially among
women [16]. High consumption of salt was typical for
the majority of the Lithuanian population during the en-
tire study period (daily intake was approximately 4 g in
men and 2.5 g in women) [26].
Over the study period, the prevalence of regular smok-
ing increased (by six times in women). Our data are in
line with the findings of the Lithuanian Health Behav-
iour Monitoring that showed the increasing trends in
the prevalence of daily smoking up to the year 2000, par-
ticularly among women [16]. In Soviet times, smoking
prevalence in Lithuania was traditionally low among
women, because it was socially unacceptable [13]. After
regaining independence in 1990, aggressive marketing of
tobacco products contributed to the increasing trends of
Table 4 Age-standardized mortality ratesa and trends in 45–64 year-old Lithuanian women, 1985–2013
Causes of death Years Time period
1985 2013 1985 - 2013
Rate 95 % CI Rate 95 % CI APC 95 % CI p-value
All causes of death 677.0 653.4–700.6 551.0 529.5–572.5 −0.50 −1.6–+0.7 0.400
CVD 245.2 231.0–259.3 154.4 143.1–165.7 −1.4 −2.7– −0.1 <0.05
CHD 114.6 105.0-124.3 68.4 60.9–75.9 −1.4 −3.1–+0.3 0.100
Malignant neoplasms 241.3 227.2–255.5 197.8 184.9–210.7 −0.4 −0.8– −0.0 0.041
Abbreviations: APC annual percent change, CHD coronary heart disease, CI confidence interval, CVD cardiovascular disease
aper 100,000 population
Table 5 Joinpoint regression analysis of age-standardized mortality rates in 45–64 year-old Lithuanian men and women, 1985–2013
Men Women
Joinpoints (Years) Time period APC 95 % CI p-value Joinpoints (Years) Time period APC 95 % CI p-value
All-cause mortality
1995 1985–1995 +4.4 +3.0–+5.8 <0.001 1995 1985–1995 +2.3 +1.2–+3.4 <0.001
1999 1996–1999 −6.3 −13.9–+2.0 0.123 2000 1996–2000 −4.7 −8.9– −0.2 0.040
2007 2000–2007 +2.7 +0.4–+5.1 0.022 2007 2001–2007 +2.4 −0.1–+4.9 0.055
2008–2013 −4.9 −7.6– −2.2 0.001 2008–2013 −4.6 −6.9– −2.3 0.001
CVD mortality
1994 1985–1994 +4.2 +2.7–+5.8 <0.001 1995 1985–1995 +1.9 +0.6–+3.2 0.005
1998 1995–1998 −7.6 −14.9–+0.2 0.056 2000 1996–2000 −7.6 −12.3– −2.7 0.005
2007 1999–2007 +2.7 +0.9–+4.5 0.006 2006 2001–2006 +3.4 −0.3–+7.2 0.071
2008–2013 −5.0 −7.6– −2.4 0.001 2007–2013 −5.3 −7.4– −3.3 <0.001
CHD mortality
1994 1985–1994 +4.3 +2.9–+5.8 <0.001 1995 1985–1995 +3.1 +1.6–+4.7 0.001
1998 1995–1998 −11.1 −17.6– −4.0 0.005 1999 1996–1999 −15.2 −23.1– −6.4 0.002
2006 1999–2006 +2.3 +0.5–+4.0 0.01 2006 2000–2006 +4.4 +1.0–+7.9 0.014
2007–2013 −4.0 −5.9– −2.0 0.001 2007–2013 −4.9 −7.4– −2.4 0.001
Mortality from malignant neoplasms
1993 1985–1993 +2.1 +1.3–+2.8 <0.001 1994 1985–1994 +0.5 −0.5–+1.6 0.313
2002 1993–2002 −1.8 −2.5– −1.0 <0.001 1995–2013 −0.9 −1.2– −0.5 <0.001
2007 2003–2007 +0.7 −1.5–+2.9 0.513
2008–2013 −2.9 −4.0– −1.8 <0.001
Abbreviations: APC annual percent change, CI confidence interval
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smoking prevalence mainly among young women [16].
Possibly, those women who started smoking at the age
of 20–30 years in the 1990s continued to be smokers at
the time of the last survey in 2006–2008, which resulted
in the greatest increase in the prevalence of female
smoking. According to the Lithuanian Health Behaviour
Monitoring data, since 2002, a decreasing trend in smok-
ing has been observed among men, and the increase of
smoking prevalence levelled off among women [16]. The
decline in the prevalence of regular smoking could be
predominantly attributed to tobacco control policies
implemented in Lithuania, including advertising bans,
bans of smoking in public areas, increased tobacco
taxation, and other measures [27, 28].
In our study, we found an increasing trend in the
prevalence of obesity and a decreasing trend in the
prevalence of overweight in men, whereas in females, a
decreasing trend in the prevalence of obesity was ob-
served. Globally, the prevalence of overweight increased
from 24.6 % in 1980 to 34.4 % in 2008 [29]. The preva-
lence of obesity increased by 1.9 times (6.4 % in 1980 vs.
12 % in 2008). In the Soviet era, the prevalence of obes-
ity was particularly high in Lithuania. According to the
data from the WHO MONICA study (1983–1985),
mean BMI of the Lithuanian population was the highest
among 34 populations participating in the study [30].
After regaining independence in the early 1990s, signifi-
cant economic, social, and psychological problems had
an impact on the lifestyle and body weight of Lithuanians.
Our data revealed that between 1986 and 1993, the preva-
lence of obesity decreased from 25.2 to 20.6 % in men and
from 50.4 to 37.2 % in women. In subsequent years, the
growing economy improved living conditions in the
country. The availability and variety of foods, including
low-cost energy-dense foods, increased considerably.
Dietary surveys showed some positive changes in the
nutrition habits of Lithuanians, such as a decrease in
the consumption of animal fat and fatty milk products,
as well as an increase in the intake of fresh vegetables
and fruits [31]. These changes were more common in
women than in men, partly explaining sex differences
in the time trends of overweight and obesity over the
last 15 years. According to the self-reported data of the
Lithuanian Health Behaviour Monitoring, the propor-
tion of obese men aged 25–64 increased from 10.7 % in
1994 to 19.5 % in 2014, while in women, the prevalence
of obesity was similar in the first and the last surveys,
19.2 and 17.3 %, respectively [32]. Due to changes in
the Lithuanian economic sector, demand for physical
activity in the workplace decreased, while leisure-time
physical activity did not change substantially [13, 16].
Furthermore, the proportion of Lithuanians walking or
riding a bicycle to and from work decreased because of
the use of private cars [16]. The decrease in physical
activity may contribute to the increase in the preva-
lence of obesity in men.
The favourable changes in mean levels of lipids among
both Lithuanian men and women correspond to the
global changes in these factors. Globally, mean total
cholesterol levels showed a decreasing trend by less than
0.1 mmol/L per decade for both men and women between
1980 and 2008 [33]. The positive changes in lipid levels
could be attributable to the changes in dietary intake. Our
previous study demonstrated the favourable trends in fatty
acid composition of the diet of Lithuanians, caused by in-
creased use of vegetable oil for cooking and replacement
of butter spread with margarine [14]. The percentage of
energy from saturated fatty acids has decreased from
18.0 to 15.1 % among men and from 17.6 to 14.8 %
among women over the period of 20 years. Total dietary
effect accounts for a 0.26 mmol/l (43.3 %) decline in
serum cholesterol in men and a 0.31 mmol/l (50.8 %)
decrease in women [14].
A decreasing trend in all-cause, CVD, and CHD mor-
tality was determined among both Lithuanian men and
women, starting from 2007 to 2008. Mortality from ma-
lignant neoplasms started to decrease from 1995 in
women and from 2007 in men. In Europe, decreasing
trends in both all-cause and CVD mortality were ob-
served much earlier than in Lithuania [6, 34, 35]. Most
researchers trying to explain the decline in mortality
from CVD and CHD suggest that favourable changes of
risk factors explain this decline to a greater extent, as
compared to treatments of these diseases. For example,
approximately 60 % of the CHD mortality decline in the
U.K. between 1981 and 2000 was attributable to the
reduction in major risk factors and 40 % to combined ef-
fects of modern treatments [34]. From years 1969–1972
to 2012, CHD mortality decreased by 82 % in Finnish
men and by 84 % in Finnish women aged 35–64 years
[36]. During the first 10 years of the study, changes in
systolic blood pressure, cholesterol level, and smoking
contributed to nearly all of the observed mortality re-
duction. In the last 10 years of the study, 69 % of the re-
duction in men and 66 % in women could be explained
by changes in those three main risk factors.
In Lithuania, both favourable and unfavourable trends
in the prevalence of risk factors were found. More positive
changes were observed in the risk profile of women. This
fact might partially explain the gender differences in the
mortality trends. In Western countries, CVD mortality
has declined continuously since the 1960s [37]. On the
contrary, the data of joinpoint regression analysis revealed
fluctuating mortality trends in the Lithuanian population.
The periods of increase and decrease in CVD mortality
closely corresponded to the trends in risk factors. De-
creasing trends in mortality from malignant neoplasms
contradict increasing trends in smoking prevalence. The
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negative effect of smoking might occur later, particularly
in women.
The study period was characterised by dramatic polit-
ical, economic, and social changes in Lithuania, which
increased the gap between socio-economic groups
[38, 39] The previous studies carried out in Lithuania
demonstrated a strong association between socio-
economic determinants and mortality rates [2, 17, 40, 41].
Higher mortality rates in lower socio-economic groups
might be caused by such underlying factors as lifestyle, ac-
cess to health care, and health promotion measures.
Socio-economic differences in lifestyle habits (diet,
physical activity, smoking, and alcohol consumption)
of Lithuanians were revealed in several studies [16, 31, 32].
Thus, a strong link between mortality and alcohol
consumption trends has been demonstrated [42, 43].
The decline in mortality observed in Lithuania from 1995
stopped in 2000, when alcohol taxes were decreased
resulting in increased alcohol consumption [43]. Alcohol
consumption causes considerable social and health prob-
lems in the country, including acute effects of alcohol on
the risk of CVD death [42].
The strength of our study is that we analysed trends of
mean levels and prevalence of risk factors (both lifestyle
and biological) and mortality (both all-cause and cause-
specific) using nationally representative data for a period
of over two decades. Some limitations should be consid-
ered when interpreting our findings. First, the present
study is limited due to its cross-sectional nature. Conse-
quently, causes and effects could not be established
directly. Second, other variables and risk factors, such as
socio-economic status, physical activity, and dietary
factors, which may have an impact on mortality rates,
were not considered. However, our study primarily
focused on the trends in more proximal risk factors of
chronic non-communicable diseases (such as blood
pressure, blood lipids, and smoking), since these risk fac-
tors explain, to a large degree, the association between
higher mortality and more distal health determinants,
such as socio-economic status [44]. Third, the age group
included in our study for the analysis of trends in the
prevalence and mean levels of risk factors is relatively
narrow: 45 to 64 years. The age range in different surveys
varied from 25 to 72 years, but only the age group 45–
64 years was suitable for the analysis throughout the
whole study period. Finally, the response rates that did not
exceed 70 % might have resulted in selection bias and
potential underestimation of the risk factor levels and
prevalence, if non-response was associated with a more
adverse risk profile. While the strength of this association
is problematic to assess (data on risk factors in non-
responders were not available), its magnitude was unlikely
to change substantially between the surveys. This,
together with the fact that the response rates were relatively
similar over time, minimizes the potential impact of non-
response on our estimates of the trends in risk factors.
Conclusions
Some favourable trends in the risk profile and mortality
of the Lithuanian population aged 45–64 were deter-
mined between 1985 and 2013. Despite these favourable
changes, the prevalence of risk factors and mortality
from main non-communicable diseases in Lithuania are
still high. Therefore, appropriate primary and secondary
prevention, as well as optimal treatment of these
diseases, remain important health policy goals.
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